Medicaments for the treatment of disorders of lipometabolism and their
申请人:Bayer Aktiengesellschaft
公开号:US04405644A1
公开(公告)日:1983-09-20
The invention relates primarily to pharmaceutical compositions and medicaments containing a compound of Formula (I), infra as the active ingredient. Also included in the invention are methods for combatting lipometabolic illnesses by administration of an active compound of the invention alone, in combination with a diluent or in the form of a medicament.